Market Research Reports and Industry Reports

Asian Internal Neurostimulaiton/Neuromodulation Market, by Modality (Spinal Cord Stimulator, Deep Brain Stimulator, Sacral Nerve Stimulator, Vagus Nerve Stimulator, Gastric Neurostimulator) -Forecast to 2019

  • DESCRIPTION
  • TABLE OF
    CONTENTS
  • RELATED
    REPORTS
  • SAMPLE REQUEST
  • PURCHASE BY
    SECTION

The Asia-Pacific internal neurostimulation/neuromodulation market is estimated to register a CAGR of 13.8% between 2014 and 2019. Although the mature market of Japan holds the largest share in the internal neurostimulation/neuromodulation market, India is estimated to register the highest CAGR of 15.3% during the forecast period. The growth of the internal neurostimulation/neuromodulation market in Asia-Pacific is driven by public initiatives to increase awareness, technological developments, growing demand for the use of advanced technologies, and increasingly aging population. However, factors including lack of skilled professional and unfavorable reimbursement scenario are restraining the growth of this market.
 
 In this report, the Asia-Pacific internal neurostimulation/neuromodulation market has been broadly classified into spinal cord stimulator, deep brain stimulator, sacral nerve stimulator, vagus nerve stimulator, and gastric neurostimulator. The Spinal Cord Stimulator segment is further categorized by application into Chronic Pain, Failed Back Surgery Syndrome, Ischemic Pain and others. Likewise, Deep Brain Stimulation market has its application in Parkinsons Disease, Tremor, Depression, and others including Chronic Pain, Dystonia, Tourettes Syndrome, and Alzheimers disease. Sacral Nerve Stimulation market has applications in Urinary Incontinence and Fecal Incontinence, while Vagus Nerve Stimulator comprises Epilepsy and other applications. Gastric Stimulation includes gastroparesis and others. The gastric neurostimulator market segment is estimated to register the highest CAGR between 2014 and 2019. The driver for this market is the increasing number of people suffering from severe GERD and gastroparesis. Most incidences of delayed bowel movement go unnoticed, which offers a significant growth opportunity for players in this segment.
 
 In terms of countries, Japan is estimated to command the largest share of 53.0% of the Asia-Pacific internal neurostimulation/neuromodulation market in 2014, followed by China. The internal neurostimulation/neuromodulation market in the Japan is primarily driven by factors including aging population, technological advancements, and rising government initiatives.
 
 The Asia-Pacific Internal neurostimulation/neuromodulation market is a competitive market with a number of market players with niche technologies. As of 2014, this market was dominated by Medtronic Inc. (U.S.), St. Jude Medical Inc. (U.S.), Boston Scientific Inc. (U.S.) Depuy Synthes, Inc. (U.S.), Cyberonics Inc. (U.S.), Enteromedics Inc. (U.S.), and Uroplasty, Inc. (U.S.) New product launches and partnerships, agreements, collaborations, and joint ventures are the main strategies adopted by most market players to achieve growth.
 
 Reasons to Buy the Report:
 
 From an insight perspective, this research report focuses on various levels of analysis—industry analysis (industry trends, and PEST analysis), market share analysis of top players, supply chain analysis, and company profiles, which together comprise and discuss the basic views on the competitive landscape, emerging and high-growth segments of the Asia-Pacific internal neurostimulation/neuromodulation market, regulatory policies of different countries, government initiatives, drivers, restraints, and upcoming opportunities.
 
 The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help the firms in garnering a greater market share. Firms purchasing the report could use any one or combination of the below mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market share.
 
 The report provides insights on the following pointers:
 
 • Market Penetration: Comprehensive information on internal neuromodulation technologies offered by the top 10 players in the neuromodulation technologies market
 • Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and new product launches in the Asia-Pacific internal neurostimulation/neuromodulation market
 
 • Market Development: Comprehensive information about emerging markets. The report analyzes the markets for various segments of the Asia-Pacific internal neurostimulation/neuromodulation market across geographies
 
 • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the Asia-Pacific internal neurostimulation/neuromodulation market
 
 • Competitive Assessment: In-depth assessment of market shares, strategies, products, and manufacturing capabilities of leading players in the Asia-Pacific internal neurostimulation/neuromodulation market 

1 INTRODUCTION 13
 1.1 OBJECTIVES OF THE STUDY 13
 1.2 MARKET SEGMENTATION & COVERAGE 14
 1.3 STAKEHOLDERS 15
 
 2 RESEARCH METHODOLOGY 16
 2.1 INTEGRATED ECOSYSTEM OF THE INTERNAL NEUROSTIMULATION / NEUROMODULATION MARKET 16
 2.2 ARRIVING AT THE NEUROMOSTIMULATION/NEUROMODULATION MARKET SIZE 17
 2.2.1 MARKET SHARE 17
 2.2.2 TOP-DOWN APPROACH 17
 2.2.3 BOTTOM-UP APPROACH 18
 2.2.4 MACRO INDICATOR-BASED APPROACH 19
 2.3 ASIA-PACIFIC INTERNAL NEUROMODULATION/NEUROSTIMULATION MARKET: MACRO INDICATORS, BY GEOGRAPHY, 2014 ($ BN) 19
 2.4 ASSUMPTIONS 20
 
 3 EXECUTIVE SUMMARY 21
 
 4 MARKET OVERVIEW 23
 4.1 INTRODUCTION 23
 4.2 INTERNAL NEUROSTIMULATION/NEUROMODULATION MARKET: COMPARISON WITH THE PARENT MARKET 23
 4.3 MARKET DRIVERS AND INHIBITORS 25
 
 5 INTERNAL NEUROSTIMULATION/NEUROMODULATION MARKET, BY MODALITY 27
 5.1 INTRODUCTION 28
 5.2 SPINAL CORD STIMULATION 29
 5.3 DEEP BRAIN STIMULATION 31
 5.4 SACRAL NERVE STIMULATION 33
 5.5 VAGUS NERVE STIMULATON 35
 5.6 GASTRIC ELECTRICAL STIMULATION (GES) 37
 
 6 INTERNAL NEUROSTIMULATION/NEUROMODULATION MARKET, BY APPLICATION 40
 6.1 INTRODUCTION 41
 6.1.1 ASIA-PACIFIC SPINAL CORD STIMULATION (SCS) MARKET, BY APPLICATION 41
 6.1.2 ASIA-PACIFIC DEEP BRAIN STIMULATION (DBS) MARKET, BY APPLICATION 43
 6.1.3 SACRAL NERVE STIMULATION (SNS) MARKET, BY APPLICATION 46
 6.1.4 VAGUS NERVE STIMULATION (VNS) MARKET, BY APPLICATION 47
 6.1.5 GASTRIC ELECTRICAL STIMULATION (GES) MARKET, BY APPLICATION 49
 
 7 INTERNAL NEUROSTIMULATION/NEUROMODULATION MARKET, BY GEOGRAPHY 51
 7.1 INTRODUCTION 52
 7.1.1 JAPAN INTERNAL NEUROSTIMULATION MARKET, BY MODALITY 52
 7.1.2 SPINAL CORD STIMULATION (SCS) NEUROSTIMULATION MARKET IN JAPAN,
 BY APPLICATION 54
 7.1.3 DEEP BRAIN STIMULATION (DBS) NEUROSTIMULATION MARKET IN JAPAN,
 BY APPLICATION 55
 7.1.4 CHINA INTERNAL NEUROSTIMULATION MARKET, BY MODALITY 59
 7.1.5 SPINAL CORD STIMULATION (SCS) NEUROSTIMULATION MARKET IN CHINA,
 BY APPLICATION 60
 7.1.6 DEEP BRAIN STIMULATION (SCS) NEUROSTIMULATION MARKET IN CHINA,
 BY APPLICATION 61
 7.1.7 DEEP BRAIN STIMULATION (SCS) NEUROSTIMULATION MARKET IN CHINA,
 BY APPLICATION 62
 7.1.8 INDIA INTERNAL NEUROSTIMULATION MARKET, BY MODALITY 65
 7.1.9 SPINAL CORD STIMULATION (SCS) NEUROSTIMULATION MARKET IN INDIA,
 BY APPLICATION 66
 7.1.10 DEEP BRAIN STIMULATION (SCS) NEUROSTIMULATION MARKET IN INDIA,
 BY APPLICATION 67
 7.1.11 REPUBLIC OF KOREA INTERNAL NEUROSTIMULATION MARKET, BY MODALITY 71
 7.1.12 DEEP BRAIN STIMULATION (DBS) NEUROSTIMULATION MARKET IN REPUBLIC OF KOREA, BY APPLICATION 73
 7.1.13 REST OF ASIA INTERNAL NEUROSTIMULATION MARKET, BY MODALITY 77
 7.1.14 SPINAL CORD STIMULATION (SCS) NEUROSTIMULATION MARKET IN REST OF ASIA, BY APPLICATION 78
 7.1.15 DEEP BRAIN STIMULATION (DBS) NEUROSTIMULATION MARKET IN REST OF ASIA, BY APPLICATION 79
 
 8 INTERNAL NEUROSTIMULATION/NEUROMODULATION MARKET: COMPETITIVE LANDSCAPE 83
 8.1 INTERNAL NEUROSTIMULATION/NEUROMODULATION MARKET: BY COMPANY 83
 8.2 NEW PRODUCT LAUNCH 84
 
 9 INTERNAL NEUROSTIMULATION/ NEUROMODULATION MARKET, BY COMPANY 85
 (Overview, Financials, Products & Services, Strategy, and Developments)*
 9.1 BOSTON SCIENTIFIC CORPORATION (U.S.) 85
 9.2 CERBOMED GMBH (GERMANY) 88
 9.3 CYBERONICS, INC. (U.S.) 89
 9.4 DEPUY SYNTHES COMPANIES (U.S.) 91
 9.5 ENTEROMEDICS, INC. (U.S.) 93
 9.6 MEDTRONIC, INC. (U.S.) 95
 9.7 ST. JUDE MEDICAL (U.S.) 98
 9.8 SYNAPSE BIOMEDICAL, INC. (U.S.) 101
 9.9 UROPLASTY, INC. (U.S.) 102
 *Details on overview, financials, product & services, strategy, and developments might not be captured in case of unlisted company
 
 10 APPENDIX 104
 10.1 CUSTOMIZATION OPTIONS 104
 10.1.1 PRODUCT ANALYSIS 104
 10.1.2 EPIDEMIOLOGY DATA 104
 10.1.3 SURGEONS/PHYSICIANS PERCEPTION ANALYSIS 104
 10.1.4 REGULATORY FRAMEWORK 104
 10.2 RELATED REPORTS 105
 10.3 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 106
 10.3.1 SNAPSHOTS 107


List Of Tables

TABLE 1 ASIA-PACIFIC INTERNAL NEUROSTIMULATION/NEUROMODULATION MARKET: COMPARISON WITH PARENT MARKET, 2013 – 2018 (USD MN) 24
 TABLE 2 INTERNAL NEUROMODULATION/NEUROSTIMULATION MARKET, BY GEOGRAPHY, 2013 - 2019 (USD THOUSAND) 24
 TABLE 3 INTERNAL NEUROMODULATION/NEUROSTIMULATION MARKET IN ASIA-PACIFIC: DRIVERS AND INHIBITORS 25
 TABLE 4 INTERNAL NEUROSTIMULATION/NEUROMODULATION MARKET IN ASIA-PACIFIC,
 BY MODALITY, 2013 - 2019 (USD THOUSAND) 28
 TABLE 5 SPINAL CORD STIMULATION MARKET, BY GEOGRAPHY, 2013–2019 (USD THOUSAND) 30
 TABLE 6 DEEP BRAIN STIMULATION MARKET, BY GEOGRAPHY, 2013–2019 (USD THOUSAND) 33
 TABLE 7 SACRAL NERVE STIMULATION MARKET, BY GEOGRAPHY, 2013–2019 (USD THOUSAND) 35
 TABLE 8 VAGUS NERVE STIMULATION MARKET, BY GEOGRAPHY, 2013–2019 (USD THOUSAND) 37
 TABLE 9 GASTRIC ELECTRICAL STIMULATION MASKS MARKET, BY GEOGRAPHY,
 2013–2019 (USD THOUSAND) 38
 TABLE 10 ASIA-PACIFIC SPINAL CORD STIMULATION (SCS) MARKET, BY APPLICATION,
 2013 - 2019 (USD THOUSAND) 42
 TABLE 11 ASIA-PACIFIC DEEP BRAIN STIMULATION (DBS) MARKET, BY APPLICATION,
 2013 - 2019 (USD THOUSAND) 44
 TABLE 12 ASIA-PACIFIC SACRAL NERVE STIMULATION (SNS) MARKET, BY APPLICATION,
 2013 - 2019 (USD THOUSAND) 46
 TABLE 13 ASIA-PACIFIC VAGUS NERVE STIMULATION (VNS) MARKET, BY APPLICATION,
 2013 - 2019 (USD THOUSAND) 48
 TABLE 14 ASIA-PACIFIC GASTRIC ELECTRIC STIMULATION (GES) MARKET, BY APPLICATION,
 2013 - 2019 (USD THOUSAND) 49
 TABLE 15 INTERNAL NEUROSTIMULATION/NEUROMODULATION MARKET IN JAPAN,
 BY MODALITY, 2013 - 2019 (USD THOUSAND) 53
 TABLE 16 SPINAL CORD STIMULATION (SCS) MARKET IN JAPAN, BY APPLICATION,
 2013 - 2019 (USD THOUSAND) 54
 TABLE 17 DEEP BRAIN STIMULATION (DBS) MARKET IN JAPAN, BY APPLICATION,
 2013 - 2019 (USD THOUSAND) 55
 TABLE 18 SACRAL NERVE STIMULATION (SNS) MARKET IN JAPAN, BY APPLICATION,
 2013 - 2019 (USD THOUSAND) 56
 TABLE 19 VAGUS NERVE STIMULATION (VNS) MARKET IN JAPAN, BY APPLICATION,
 2013 - 2019 (USD THOUSAND) 57
 TABLE 20 GASTRIC ELECTRICAL STIMULATION (GES) MARKET IN JAPAN, BY APPLICATION,
 2013 - 2019 (USD THOUSAND) 58
 TABLE 21 INTERNAL NEUROSTIMULATION/NEUROMODULATION MARKET IN CHINA,
 BY MODALITY, 2013 - 2019 (USD THOUSAND) 59
 TABLE 22 SPINAL CORD STIMULATION (SCS) MARKET IN CHINA, BY APPLICATION,
 2013 - 2019 (USD THOUSAND) 61
 TABLE 23 DEEP BRAIN STIMULATION (DBS) MARKET IN CHINA, BY APPLICATION,
 2013 - 2019 (USD THOUSAND) 62
 TABLE 24 SACRAL NERVE STIMULATION (SNS) MARKET IN CHINA, BY APPLICATION,
 2013 - 2019 (USD THOUSAND) 63
 TABLE 25 VAGUS NERVE STIMULATION (VNS) MARKET IN CHINA, BY APPLICATION,
 2013 - 2019 (USD THOUSAND) 63
 TABLE 26 GASTRIC ELECTRICAL STIMULATION (GES) MARKET IN CHINA, BY APPLICATION,
 2013 - 2019 (USD THOUSAND) 64
 TABLE 27 INTERNAL NEUROSTIMULATION/NEUROMODULATION MARKET IN INDIA,
 BY MODALITY, 2013 - 2019 (USD THOUSAND) 65
 TABLE 28 SPINAL CORD STIMULATION (SCS) MARKET IN INDIA, BY APPLICATION,
 2013 - 2019 (USD THOUSAND) 67
 TABLE 29 DEEP BRAIN STIMULATION (DBS) MARKET IN INDIA, BY APPLICATION,
 2013 - 2019 (USD THOUSAND) 68
 TABLE 30 SACRAL NERVE STIMULATION (SNS) MARKET IN INDIA, BY APPLICATION,
 2013 - 2019 (USD THOUSAND) 69
 TABLE 31 VAGUS NERVE STIMULATION (VNS) MARKET IN INDIA, BY APPLICATION,
 2013 - 2019 (USD THOUSAND) 69
 TABLE 32 GASTRIC ELECTRICAL STIMULATION (GES) MARKET IN INDIA, BY APPLICATION,
 2013 - 2019 (USD THOUSAND) 70
 TABLE 33 INTERNAL NEUROSTIMULATION/NEUROMODULATION MARKET IN REPUBLIC OF KOREA, BY MODALITY, 2013 - 2019 (USD THOUSAND) 71
 TABLE 34 SPINAL CORD STIMULATION (SCS) MARKET IN REPUBLIC OF KOREA, BY APPLICATION, 2013 - 2019 (USD THOUSAND) 73
 TABLE 35 DEEP BRAIN STIMULATION (DBS) MARKET IN REPUBLIC OF KOREA, BY APPLICATION, 2013 - 2019 (USD THOUSAND) 74
 TABLE 36 SACRAL NERVE STIMULATION (SNS) MARKET IN REPUBLIC OF KOREA,
 BY APPLICATION, 2013 - 2019 (USD THOUSAND) 75
 TABLE 37 VAGUS NERVE STIMULATION (VNS) MARKET IN REPUBLIC OF KOREA,
 BY APPLICATION, 2013 - 2019 (USD THOUSAND) 75
 TABLE 38 GASTRIC ELECTRICAL STIMULATION (GES) MARKET IN REPUBLIC OF KOREA,
 BY APPLICATION, 2013 - 2019 (USD THOUSAND) 76
 TABLE 39 INTERNAL NEUROSTIMULATION/NEUROMODULATION MARKET IN REST OF ASIA,
 BY MODALITY, 2013 - 2019 (USD THOUSAND) 77
 TABLE 40 SPINAL CORD STIMULATION (SCS) MARKET IN REST OF ASIA, BY APPLICATION,
 2013 - 2019 (USD THOUSAND) 79
 TABLE 41 DEEP BRAIN STIMULATION (DBS) MARKET IN REST OF ASIA, BY APPLICATION,
 2013 - 2019 (USD THOUSAND) 80
 TABLE 42 SACRAL NERVE STIMULATION (SNS) MARKET IN REST OF ASIA, BY APPLICATION,
 2013 - 2019 (USD THOUSAND) 81
 TABLE 43 VAGUS NERVE STIMULATION (VNS) MARKET IN REST OF ASIA, BY APPLICATION,
 2013 - 2019 (USD THOUSAND) 81
 TABLE 44 GASTRIC ELECTRICAL STIMULATION (GES) MARKET IN REST OF ASIA, BY APPLICATION, 2013 - 2019 (USD THOUSAND) 82
 TABLE 45 ASIA-PACIFIC INTERNAL NEUROMODULATION MARKET: NEW PRODUCT LAUNCH 84
 TABLE 46 REGULATORY APPROVALS ASIA-PACIFIC INTERNAL NEUROMODULATION MARKET: REGULATORY APPROVALS 84
 TABLE 47 BOSTON SCIENTIFIC CORPORATION: KEY FINANCIALS,BY SEGMENT,
 2009 – 2013 (USD MILLION) 86
 TABLE 48 BOSTON SCIENTIFIC: KEY FINANCIALS, BY GEOGRAPHY, 2009 – 2012 (USD MILLION) 86
 TABLE 49 CYBERONICS, INC.: KEY FINANCIALS, 2009 - 2013 (USD MILLION) 89
 TABLE 50 JOHNSON & JOHNSON, INC. : KEY FINANCIALS, BY SEGMENT,
 2009 - 2013 (USD MILLION) 92
 TABLE 51 JOHNSON & JOHNSON, INC.: KEY FINANCIALS, 2009 - 2013 (USD MILLION) 92
 TABLE 52 MEDTRONIC, INC. : KEY FINANCIALS, BY SEGMENT, 2009 - 2013 (USD MILLION) 96
 TABLE 53 MEDTRONIC, INC. : KEY FINANCIALS, 2009 - 2013 (USD MILLION) 96
 TABLE 54 ST. JUDE MEDICAL: KEY FINANCIALS, BY SEGMENT, 2011 - 2013 (USD MILLION) 99
 TABLE 55 ST. JUDE MEDICAL: KEY FINANCIALS, BY GEOGRAPHY, 2008 - 2013 (USD MILLION) 99
 TABLE 56 UROPLASTY, INC. : KEY FINANCIALS, BY GEOGRAPHY, 2011 - 2013 (USD MILLION) 102


List Of Figures

FIGURE 1 ASIA-PACIFIC NEUROSTIMULATION/NEUROMODULATION MARKET SEGMENTATION & COVERAGE 14
 FIGURE 2 INTERNAL NEUROSTIMULATION/NEUROMODULATION MARKET: INTEGRATED ECOSYSTEM 16
 FIGURE 3 TOP-DOWN APPROACH 17
 FIGURE 4 INTERNAL NEUROSTIMULATION/NEUROMODULATION MARKET IN ASIA-PACIFIC,
 BY COUNTRY, 2013–2019 (USD MN) 24
 FIGURE 5 ASIA-PACIFIC INTERNAL NEUROSTIMULATION/NEUROMODULATION MARKET,
 BY MODALITY, 2013–2019 (USD THOUSAND) 28
 FIGURE 6 SPINAL CORD STIMULATION MARKET, BY GEOGRAPHY, 2013–2019 (USD THOUSAND) 30
 FIGURE 7 DEEP BRAIN STIMULATION MARKET, BY GEOGRAPHY, 2013–2019 (USD THOUSAND) 32
 FIGURE 8 SACRAL NERVE STIMULATION MARKET, BY GEOGRAPHY, 2013–2019 (USD THOUSAND) 34
 FIGURE 9 VAGUS NERVE STIMULATION MARKET, BY GEOGRAPHY, 2013–2019 (USD THOUSAND) 36
 FIGURE 10 GASTRIC ELECTRICAL STIMULATION MASKS MARKET, BY GEOGRAPHY,
 2013–2019 (USD THOUSAND) 38
 FIGURE 11 INTERNAL NEUROSTIMULATION/NEUROMODULATION MARKET IN JAPAN,
 BY MODALITY, 2013–2019 (USD THOUSAND) 53
 FIGURE 12 SPINAL CORD STIMULATION (SCS) MARKET IN JAPAN, BY APPLICATION,
 2013 - 2019 (USD THOUSAND) 54
 FIGURE 13 DEEP BRAIN STIMULATION (DBS) MARKET IN JAPAN, BY APPLICATION,
 2013 - 2019 (USD THOUSAND) 55
 FIGURE 14 SACRAL NERVE STIMULATION (SNS) MARKET IN JAPAN, BY APPLICATION,
 2013 - 2019 (USD MN) 56
 FIGURE 15 VAGUS NERVE STIMULATION (VNS) MARKET IN JAPAN, BY APPLICATION,
 2013 - 2019 (USD MN) 57
 FIGURE 16 GASTRIC ELECTRICAL STIMULATION (GES) MARKET IN JAPAN, BY APPLICATION,
 2013 - 2019 (USD THOUSAND) 58
 FIGURE 17 CHINA INTERNAL NEUROSTIMULATION MARKET OVERVIEW, 2014 & 2019 (%) 59
 FIGURE 18 INTERNAL NEUROSTIMULATION/NEUROMODULATION MARKET IN CHINA,
 BY MODALITY, 2013–2019 (USD THOUSAND) 60
 FIGURE 19 SPINAL CORD STIMULATION (SCS) MARKET IN CHINA, BY APPLICATION,
 2013 - 2019 (USD THOUSAND) 60
 FIGURE 20 DEEP BRAIN STIMULATION (DBS) MARKET IN CHINA, BY APPLICATION,
 2013 - 2019 (USD THOUSAND) 61
 FIGURE 21 SACRAL NERVE STIMULATION (SNS) MARKET IN CHINA, BY APPLICATION,
 2013 - 2019 (USD THOUSAND) 62
 FIGURE 22 VAGUS NERVE STIMULATION (VNS) MARKET IN CHINA, BY APPLICATION,
 2013 - 2019 (USD THOUSAND) 63
 FIGURE 23 GASTRIC ELECTRICAL STIMULATION (GES) MARKET IN CHINA, BY APPLICATION,
 2013 - 2019 (USD THOUSAND) 64
 FIGURE 24 INDIA INTERNAL NEUROSTIMULATION MARKET OVERVIEW, 2014 & 2019 (%) 65
 FIGURE 25 INTERNAL NEUROSTIMULATION/NEUROMODULATION MARKET IN INDIA,
 BY MODALITY, 2013–2019 (USD THOUSAND) 66
 FIGURE 26 SPINAL CORD STIMULATION (SCS) MARKET IN INDIA, BY APPLICATION,
 2013 - 2019 (USD THOUSAND) 66
 FIGURE 27 DEEP BRAIN STIMULATION (DBS) MARKET IN INDIA, BY APPLICATION,
 2013 - 2019 (USD THOUSAND) 67
 FIGURE 28 SACRAL NERVE STIMULATION (SNS) MARKET IN INDIA, BY APPLICATION,
 2013 - 2019 (USD THOUSAND) 68
 FIGURE 29 VAGUS NERVE STIMULATION (VNS) MARKET IN INDIA, BY APPLICATION,
 2013 - 2019 (USD THOUSAND) 69
 FIGURE 30 GASTRIC ELECTRICAL STIMULATION (GES) MARKET IN INDIA, BY APPLICATION,
 2013 - 2019 (USD THOUSAND) 70
 FIGURE 31 REPUBLIC OF KOREA INTERNAL NEUROSTIMULATION MARKET OVERVIEW,
 2014 & 2019 (%) 71
 FIGURE 32 INTERNAL NEUROSTIMULATION/NEUROMODULATION MARKET IN REPUBLIC OF KOREA, BY MODALITY, 2013–2019 (USD THOUSAND) 72
 FIGURE 33 SPINAL CORD STIMULATION (SCS) MARKET IN REPUBLIC OF KOREA, BY APPLICATION, 2013 - 2019 (USD THOUSAND) 72
 FIGURE 34 DEEP BRAIN STIMULATION (DBS) MARKET IN REPUBLIC OF KOREA, BY APPLICATION, 2013 - 2019 (USD THOUSAND) 73
 FIGURE 35 SACRAL NERVE STIMULATION (SNS) MARKET IN REPUBLIC OF KOREA,
 BY APPLICATION, 2013 - 2019 (USD THOUSAND) 74
 FIGURE 36 VAGUS NERVE STIMULATION (VNS) MARKET IN REPUBLIC OF KOREA,
 BY APPLICATION, 2013 - 2019 (USD THOUSAND) 75
 FIGURE 37 GASTRIC ELECTRICAL STIMULATION (GES) MARKET IN REPUBLIC OF KOREA,
 BY APPLICATION, 2013 - 2019 (USD THOUSAND) 76
 FIGURE 38 REST OF ASIA INTERNAL NEUROSTIMULATION MARKET OVERVIEW, 2014 & 2019 (%) 77
 FIGURE 39 INTERNAL NEUROSTIMULATION/NEUROMODULATION MARKET IN REST OF ASIA,
 BY MODALITY, 2013–2019 (USD THOUSAND) 78
 FIGURE 40 SPINAL CORD STIMULATION (SCS) MARKET IN REST OF ASIA, BY APPLICATION,
 2013 - 2019 (USD THOUSAND) 78
 FIGURE 41 DEEP BRAIN STIMULATION (DBS) MARKET IN REST OF ASIA, BY APPLICATION,
 2013 - 2019 (USD THOUSAND) 79
 FIGURE 42 SACRAL NERVE STIMULATION (SNS) MARKET IN REST OF ASIA, BY APPLICATION,
 2013 - 2019 (USD THOUSAND) 80
 FIGURE 43 VAGUS NERVE STIMULATION (VNS) MARKET IN REST OF ASIA, BY APPLICATION,
 2013 - 2019 (USD THOUSAND) 81
 FIGURE 44 GASTRIC ELECTRICAL STIMULATION (GES) MARKET IN REST OF ASIA, BY APPLICATION, 2013 - 2019 (USD THOUSAND) 82
 FIGURE 45 INTERNAL NEUROSTIMULATION/ NEUROMODULATION MARKET: BY COMPANY 83
 FIGURE 46 BOSTON SCIENTIFIC CORPORATION REVENUE MIX, 2013 85
 FIGURE 47 JOHNSON & JOHNSON, INC. REVENUE MIX, 2013 91
 FIGURE 48 MEDTRONIC, INC. REVENUE MIX, 2013 95
 FIGURE 49 ST. JUDE MEDICAL. REVENUE MIX, 2013 98


PetroAsian Energy Holdings Limited Company Profile- Outlook, Business Segments, Competitors, Goods and Services, SWOT and Financial Analysis

PetroAsian Energy Holdings Limited Company Profile is a complete analysis of the companys operations, strategies, outlook and historic performance. The research work analyzes key strategies in current market conditions,

USD 200View Report

Panasian Limited Company Profile- Outlook, Business Segments, Competitors, Goods and Services, SWOT and Financial Analysis

Panasian Limited Company Profile is a complete analysis of the companys operations, strategies, outlook and historic performance. The research work analyzes key strategies in current market conditions, SWOT profile,

USD 200View Report

Fidelity Asian Values PLC Company Profile- Outlook, Business Segments, Competitors, Goods and Services, SWOT and Financial Analysis

Fidelity Asian Values PLC Company Profile is a complete analysis of the companys operations, strategies, outlook and historic performance. The research work analyzes key strategies in current market conditions,

USD 200View Report

Fill The Form For Sample Request
Name*
Email*
Mobile No.*
LandLine No.
If you want to purchase particular section from this report then kindly contact us at contact@aarkstore.com.

Delivery Details

PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)

CHOOSE FORMAT

  • PDF    $ 2650
  • Corporate Licence    $ 4505
$ 2650

Reports Details

Published Date : Mar 2015
No. of Pages :108
Country :Asia
Category :Healthcare
Publisher :Micro Market Monitor
Report Delivery By :Email
Report Delivery Time :12 to 24 hours after placing the order.

Customized Research

If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE

 

We Accept

payment